Currently out of the existing stock ratings of Eric Joseph, 73 are a BUY (52.52%), 54 are a HOLD (38.85%), 12 are a SELL (8.63%).

Eric Joseph

Work Performance Price Targets & Ratings Chart

Analyst Eric Joseph works at JPMORGAN with a stock forecast success ratio of 51.66% fulfilled within 91.71 days on average.

Eric Joseph’s has documented 269 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on LTHM, Livent Corp at 29-Nov-2023.

Wall Street Analyst Eric Joseph

Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for MNTA (MOMENTA PHARMACEUTICALS) at 1/14/2020. The price target of $30 was fulfilled within 2 days with a profit of $4.64 (18.3%) receiving and performance score of 91.48.

Average potential price target upside

AKBA Akebia Ther ALGS Aligos Therapeutics  AUTL Autolus Therapeutics Ltd AVIR Atea Pharmaceuticals  BDTX Black Diamond Therapeutics BEAM Beam Therapeutics  ENTA Enanta Pharmaceuticals FPRX Five Prime Therapeutics KPTI Karyopharm Therapeutics MNTA Momenta Pharmaceuticals MYOV Myovant Sciences Ltd NRIX Nurix Therapeutics  NVAX Novavax OBSV ObsEva SA OMER Omeros PTCT PTC Therapeutics RLAY Relay Therapeutics  RCKT Rocket Pharmaceuticals HGEN Humanigen IRWD Ironwood Pharmaceuticals TERN Terns Pharmaceuticals XLRN Acceleron Pharma CCCC C4 Therapeutics  SRZN Surrozen DTIL Precision BioSciences FRLN Freeline Therapeutics Holdings Plc IGMS IGM Biosciences OPK Opko Health PLRX Pliant Therapeutics  RVMD Revolution Medicines BMEA Biomea Fusion KYMR Kymera Therapeutics MRTX Mirati Ther GLUE Monte Rosa Therapeutics TGTX TG Therapeutics VIR Vir Biotechnology AKRO Akero Therapeutics IPSC Century Therapeutics LTHM Livent Corp RXRX Recursion Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$3.49 (231.13%)

3.75

3 months 11 days ago

4/15 (26.67%)

$4 (400.00%)

147

Buy

4

$2.49 (164.90%)

8

8 months 28 days ago

1/11 (9.09%)

$2.96 (284.62%)

4

Buy

1

$-0.51 (-33.77%)

8

1 years 10 months 27 days ago

1/2 (50%)

$0.33 (49.25%)

311

Buy

7

1 years 10 months 28 days ago

3/6 (50%)

$5.37 (107.92%)

411

Hold

2

$0.49 (32.45%)

6

1 years 10 months 28 days ago

2/9 (22.22%)

$1.28 (177.78%)

340

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Eric Joseph is most bullish on?

Potential upside of $17.1 has been obtained for AKRO (AKERO THERAPEUTICS)

Which stock is Eric Joseph is most reserved on?

Potential downside of -$5.52 has been obtained for RXRX (RECURSION PHARMACEUTICALS)

What Year was the first public recommendation made by Eric Joseph?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?